Coldstream Capital Management Inc Nuvation Bio Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,941 shares of NUVB stock, worth $4,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,941Holding current value
$4,619% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
163Shares Held
150MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$61.8 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$38.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$36.6 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$31.1 Million47.43% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$21.9 Million5.46% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $517M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...